Is ImmuPharma PLC halal to invest in?

As of September 2026, ImmuPharma PLC 25I.SG is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is ImmuPharma PLC a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes ImmuPharma PLC using these criteria to determine its compliance status.

Can Muslims buy shares of ImmuPharma PLC?

Muslim investors may consider investing in ImmuPharma PLC if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is ImmuPharma PLC classified as NOT HALAL?

Musaffa determines the Shariah status of ImmuPharma PLC by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for ImmuPharma PLC updated?

The Shariah compliance status of ImmuPharma PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like ImmuPharma PLC become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of ImmuPharma PLC?

You can check the latest Shariah compliance status of ImmuPharma PLC on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Is ImmuPharma PLC Stock Halal?

Shariah Compliance Analysis of 25I.SG Stock

Germany Health Care Nano Cap

No. As of September 2026, ImmuPharma PLC (25I.SG) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. ImmuPharma PLC does not pass Musaffa's business and financial screening criteria.

ImmuPharma Plc engages in the research, development, and commercialization of pharmaceutical products. The firm is engaged in the development of drugs, largely based on peptide therapeutics, to treat serious medical conditions such as autoimmune diseases with high medical need. Its lead program, P140, is a non-immunosuppressing, convenient and safe peptide treatment for autoimmune disease, which is in late-stage development for the treatment of systemic lupus erythematosus (SLE) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). Its pipeline products in the anti-infectives inflammation therapeutic areas include BioAMB and BioCin. BioAMB is an advanced anti-infective candidate. The company is an improved form of amphotericin-B (AMB), a systemic antifungal drug. BioCin is an improved form of vancomycin, a systemic antibacterial which is highly effective against Methicillin-resistant Staphylococcus Aureus (MRSA) and orally against Clostridium Difficile infections.

ImmuPharma PLC 25I.SG

€0.04 €0.00 (3.70%) 1D

Last Updated: Sep 09, 12:00 AM·XSTU

Pricing for DE stocks is delayed by 24 hours

25I.SG Shariah Compliance

Screening Methodology: AAOIFI

As of September 2026, ImmuPharma PLC is classified as not halal.

NOT HALAL

Report Source: undefined Quarter Report

ImmuPharma PLC (25I.SG) Chart

Financial Metrics & Statements of ImmuPharma PLC (25I.SG)

FAQ's for ImmuPharma PLC (25I.SG)

As of September 2026, ImmuPharma PLC 25I.SG is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes ImmuPharma PLC using these criteria to determine its compliance status.
Muslim investors may consider investing in ImmuPharma PLC if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of ImmuPharma PLC by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of ImmuPharma PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of ImmuPharma PLC on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Alternate Halal Stocks for ImmuPharma PLC (25I.SG)

Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.

Name	Price	1D Change	Market Cap	Rating
Merck KGaA MRK.DE	€131.65	1.49%	€59.26B	Unlock
Cantourage Group SE HIGH.DE	€5.72	0.35%	€71.31M	Unlock
Biofrontera AG B8FK.DE	€2.41	5.86%	€14.65M	Unlock